OBJECTIVES: Upon completion of this activity, the participant should be able to: 

• Describe the historical use of Tranexamic Acid (TXA) use for the traumatically injured orthopedic patient.
• Describe the safety and efficacy of TXA use in orthopedic trauma patients.
• Discuss future directions for the use of TXA.

FACULTY DISCLOSURE: Elliot Row, MD does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

PLANNER DISCLOSURE:  Michael Foreman, MD does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Baylor Scott & White Health is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.